Evidence map›Paper›PMID 30911969›Full record

ArticleEnvironmental science and pollution research international2019

The nephroprotective effects of allicin and ascorbic acid against cisplatin-induced toxicity in rats.

Mohamed M Abdel-Daim, Abdelrahman Ibrahim Abushouk, Thoria Donia, Saud Alarifi, Saad Alkahtani, Lotfi Aleya, Simona G Bungau

Abstract read
PubMed Publisher
In one paragraph

Article in Environmental science and pollution research international, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed, 1 pooled it
7.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 1 synthesis or guideline pooled it, 76 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Antioxidant, biochemical, hematological indices and handling stress resistance in rainbow trout (Veterinary research forum : an international quarterly journal · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Ameliorative Effect ofInternational journal of nephrology · 2023
    Article
  14. Article
  15. Metabolite profiling and nephroprotective potential ofIranian journal of basic medical sciences · 2022
    Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 6 institutions in 5 countries.

Mohamed M Abdel-DaimPharmacology Department, Faculty of Veterinary Medicine, Suez Canal University, Ismailia, Egypt. Abdeldaim.m@vet.suez.edu.eg.ORCID http://orcid.org/0000-0002-4341-2713
Abdelrahman Ibrahim AbushoukFaculty of Medicine, Ain Shams University, Ramsis St, Abbasia, 11566, Cairo, Egypt. Abdelrahman.abushouk@med.asu.edu.eg.ORCID http://orcid.org/0000-0003-1399-6487
Thoria DoniaChemistry Department, Faculty of Science, Tanta University, Tanta, Egypt.
Saud AlarifiDepartment of Zoology, Science College, King Saud University, Riyadh, Saudi Arabia.
Saad AlkahtaniDepartment of Zoology, Science College, King Saud University, Riyadh, Saudi Arabia.
Lotfi AleyaChrono-Environnement Laboratory, UMR CNRS 6249, Bourgogne Franche-Comté University, F-25030, Besançon Cedex, France.
Simona G BungauDepartment of Pharmacy, Faculty of Medicine and Pharmacy, University of Oradea, Oradea, Romania.
King Saud University · SAAin Shams University · EGCentre National de la Recherche Scientifique · FRSuez Canal University · EGTanta University · EGUniversity of Oradea · RO

Funding

Deanship of Scientific Research, King Saud University RGP-018
6 · The paper itself

Abstract

Cisplatin (CDDP) may induce nephrotoxicity through oxidative stress, DNA damage, and inflammation. This study was performed to evaluate the antioxidant and anti-inflammatory effects of allicin and ascorbic acid (AA) and investigate the nephroprotective efficacy of their combination against CDDP-induced intoxication. Rats were divided into seven groups: control, allicin (10 mg/kg for 14 days), AA (20 mg/kg for 14 days), CDDP (7 mg/kg as a single dose on the seventh experimental day), CDDP-allicin, CDDP-AA, and CDDP-allicin-AA (at the aforementioned doses). The administration of CDDP induced marked body weight loss and renal damage, manifested by significant increases (p < 0.05) in serum creatinine, urea, and uric acid levels and significant reductions in serum Na, Ca, and phosphorus concentrations, in addition to severe alterations in serum and renal tissue levels of tumor necrosis factor-α in comparison with control rats. Moreover, CDDP-intoxicated rats exhibited significantly (p < 0.05) higher lipid peroxidation, as well as lower levels of reduced glutathione and activities of glutathione peroxidase, superoxide dismutase, and catalase enzymes in the renal tissue, compared with control rats. The administration of allicin or AA significantly reduced (p < 0.05) the CDDP-induced changes in all the aforementioned parameters. Interestingly, allicin achieved comparable nephroprotection to AA in most assessed parameters; however, the restoration of normal serum and renal tissue concentrations of these parameters was more frequent in the CDDP-AA group. In conclusion, both allicin and AA showed significant nephroprotective effects against CDDP intoxication and their combination exhibited better protection than either agent alone. These results are probably mediated by their antioxidant and anti-inflammatory activities.

Indexed as

AnimalsAntioxidantsAscorbic AcidCatalaseCisplatinCreatinineDisulfidesGlutathioneGlutathione PeroxidaseKidney DiseasesLipid PeroxidationMaleOxidative StressRatsSulfinic AcidsSuperoxide DismutaseallicinAntioxidantsAscorbic AcidCatalaseCisplatinCreatinineDisulfidesGlutathioneGlutathione PeroxidaseSulfinic AcidsSuperoxide DismutaseUreaAllicinAscorbic acidCisplatinInflammationNephrotoxicityOxidative stress

Identifiers

PMID30911969
OpenAlexW2941133527

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.